Skip to main content
Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China flag China · Delayed Price · Currency is CNY
96.27
+0.37 (0.39%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Anti-tumor
3.51B
Log In
Log In
Log In
Log In
Upgrade
Anti-tumor Growth
77.27%
Log In
Log In
Log In
Log In
Upgrade
Technology Licensing and Service
52.30M
Log In
Log In
Log In
Log In
Upgrade
Technology Licensing and Service Growth
28.79%
Log In
Log In
Log In
Log In
Upgrade
Other
41.32K
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-35.35%
Log In
Log In
Log In
Log In
Upgrade
Lansoprazole Enteric Capsules
-
Log In
Log In
Log In
Log In
Upgrade
Lansoprazole Enteric Capsules Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
China
3.56B
Log In
Log In
Log In
Log In
Upgrade
China Growth
79.45%
Log In
Log In
Log In
Log In
Upgrade
Overseas
-
Log In
Log In
Log In
Log In
Upgrade